ArticleFrontiers in medicine2021

Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study.

Junyu Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.